Sharp downturn in nursing home COVID-19 cases, death after vaccinations started
A New York Times analysis of federal data shows that deaths declined by 65% between late December and early February.
COVID-19 incidence and mortality has dropped significantly since the beginning of the effort to vaccinate nursing home residents and staff, according to a New York Times story today.
The newspaper’s analysis of federal data found that new cases among nursing home residents fell by 80% from late December through early February and that the deaths decreased by 65%.
Nursing homes were hit hard early on during the pandemic and through much of 2020. The Kaiser Family Foundation reported in November that the death toll of long-term care residents and staff had reached 100,000.
From the beginning of April through the end of July, deaths among nursing home residents and staff accounted for about 40.6% of all COVID-19-related deaths in the U.S.
That proportion was calculated by taking the foundation’s tally of 62,718 long-term care facility deaths as of July 2020 as a percentage of the John Hopkins Coronavirus Resource Center’s cumulative COVID-19 death total of 154,500 at the end of July 31, 2020.
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
FDA Accepts NDA for Zoliflodacin, Potentially First Gonorrhea Antibiotic in Decades
June 13th 2025The FDA has accepted a New Drug Application for zoliflodacin, a first-in-class oral antibiotic for treating uncomplicated gonorrhea, offering a potential new option amid rising antibiotic resistance.
Read More
